Search for: "ACTAVIS PHARMA INC"
Results 61 - 80
of 127
Sort by Relevance
|
Sort by Date
18 Jun 2013, 7:15 am
Actavis Inc., Generic Drugs, Intellectual Property, Matt Kaiser, Monopoly, Patents, Pharmaceuticals, SCOTUS, Settlements, Supreme Court [read post]
16 Jun 2013, 9:32 pm
Watson Laboratories Inc. et al. 1:13-cv-01015; filed June 6, 2013 in the District Court of Delaware • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
2 Apr 2013, 10:33 am
Actavis (12-416). [read post]
24 Mar 2013, 8:01 pm
– Florida; Watson Pharma, Inc.; Actavis, Inc. [read post]
24 Feb 2013, 9:06 pm
• Defendants: Actavis LLC; Apotex, Inc.; Apotex Corp.; Bedford Laboratories, Inc.; Dr. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
30 Dec 2012, 9:30 pm
Actavis Inc. 1:12-cv-01750; filed December 21, 2012 in the District Court of Delaware Infringement of U.S. [read post]
16 Nov 2012, 2:30 am
The defendants in their case include Watson Laboratories Inc., Actavis Elizabeth LLC and Pliva Inc., manufacturers of the generic equivalent of Reglan, as well as Schwartz Pharma. [read post]
8 Apr 2012, 8:51 pm
Actavis Inc. et al. 1:12-cv-00323;... [read post]
26 Jan 2012, 6:57 am
The CEO of Actavis, Inc. had this to say: “Actavis will continue to report our product pricing in an [sic] manner consistent with all applicable laws as well as the terms of this agreement. [read post]
14 Aug 2011, 9:59 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
3 Aug 2011, 3:31 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
29 Jun 2011, 3:34 am
Mensing; Actavis, Inc. v. [read post]
15 Jun 2011, 4:56 am
Actavis (Kluwer Patent Blog) Viagra (Sildenafil) – US: Patent infringement complaint filed in response to Para IV certification: Pfizer Inc. et al. v. [read post]
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets … [read post]
6 Apr 2011, 12:18 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Mar 2011, 4:21 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
